(Temporarily unavailable to U.S. residents since March 2020)
The TickPlex assay is performed on the basis of an ELISA. However, compared to other ELISA assays, this test contains a new antigen for round bodies/persister forms of Borrelia.
TickPlex is an accredited test and can be used at different stages of the disease.
TickPlex Plus allows the simultaneous determination of IgM and IgG antibodies of several bacterial and viral pathogens.
With its high sensitivity of approx. 95% and a specificity of 98%, TickPlex is superior to comparable IFA test methods that have been used so far.